| 1 | Penile Neoplasms | 57% |
| 2 | Testicular Neoplasms | 39.7% |
| 3 | Benign prostatic hypertrophy | 29.1% |
| 4 | prostatitis | 29.1% |
| 5 | Prostatic Adenoma | 29.1% |
| 6 | Benign Prostatic Hyperplasia | 29.1% |
| 7 | Prostatic Hypertrophy | 29.1% |
| 8 | Prostatic Hyperplasia | 29.1% |
| 9 | Epididymitis | 28.2% |
| 10 | Penile Diseases | 28.2% |
| 11 | Spermatic Cord Torsion | 28.2% |
| 12 | Hemospermia | 28.2% |
| 13 | Testicular Hydrocele | 28.2% |
| 14 | Urologic Neoplasms | 24.4% |
| 15 | Testicular Diseases | 23.7% |
| 16 | Varicocele | 23.7% |
| 17 | Infertility | 23.5% |
| 18 | Spermatocele | 23.5% |
| 19 | Leydig Cell Tumor | 21.9% |
| 20 | Cryptorchidism | 19.2% |
| 21 | Hypospadias | 19.2% |
| 22 | Balanitis | 18.5% |
| 23 | Phimosis | 18.5% |
| 24 | Priapism | 18.5% |
| 25 | Sexually Transmitted Diseases | 18.2% |
| 26 | Genital Herpes | 17.5% |
| 27 | Genital Neoplasms, Male | 17.4% |
| 28 | Urologic Diseases | 17.3% |
| 29 | Bladder Neoplasm | 16.8% |
| 30 | Kidney Neoplasm | 16.8% |
| 31 | Ureteral Neoplasms | 16.8% |
| 32 | Urethral Neoplasms | 16.8% |
| 33 | Prostatic Neoplasms | 16.5% |
| 34 | Prostatic Diseases | 16.1% |
| 35 | Premature Ejaculation | 15.6% |
| 36 | Erectile dysfunction | 15.6% |
| 37 | Orchitis | 15.5% |
| 38 | Urogenital Abnormalities | 14.9% |
| 39 | Azoospermia | 13.8% |
| 40 | Oligospermia | 13.8% |
| 41 | Impotence, Vasculogenic | 13.8% |
| 42 | Asthenozoospermia | 13.8% |
| 43 | Teratozoospermia | 13.8% |
| 44 | Aspermia | 13.8% |
| 45 | Dyspareunia | 13.3% |
| 46 | Prostatic Neoplasms, Castration-Resistant | 12.2% |
| 47 | Mesoblastic Nephroma | 12.2% |
| 48 | Renal Cell Carcinoma | 11.7% |
| 49 | Papillary Renal Cell Carcinoma | 11.7% |
| 50 | Nephroblastoma | 11.6% |
| 51 | Genital Neoplasms, Female | 11.6% |
| 52 | Bladder Exstrophy | 11.1% |
| 53 | Epispadias | 11.1% |
| 54 | Tuberculosis, Renal | 11% |
| 55 | Abdominal Neoplasms | 10.1% |
| 56 | Head and Neck Neoplasms | 10.1% |
| 57 | Soft Tissue Neoplasms | 10.1% |
| 58 | Thoracic Neoplasms | 10.1% |
| 59 | Urinary Bladder Diseases | 10.1% |
| 60 | Kidney Diseases | 10.1% |
| 61 | Ureteral Diseases | 10.1% |
| 62 | Urethral Diseases | 10.1% |
| 63 | Urination Disorders | 10.1% |
| 64 | Urolithiasis | 10.1% |
| 65 | Multicystic Dysplastic Kidney | 9.9% |
| 66 | Anuria | 9.9% |
| 67 | Ureterolithiasis | 9.9% |
| 68 | Nephrolithiasis | 9.9% |
| 69 | Urinary Bladder Fistula | 8.8% |
| 70 | Urinary tract infection | 8.7% |
| 71 | Digestive System Neoplasms | 8.7% |
| 72 | Endocrine Gland Neoplasms | 8.7% |
| 73 | Eye Neoplasms | 8.7% |
| 74 | Nervous System Neoplasms | 8.7% |
| 75 | Denys-Drash Syndrome | 8.6% |
| 76 | Horseshoe Kidney | 8.6% |
| 77 | Bladder neck obstruction | 8.6% |
| 78 | Bone neoplasms | 8.5% |
| 79 | Skin Neoplasms | 8.5% |
| 80 | Hematologic Neoplasms | 8.5% |
| 81 | Splenic Neoplasms | 8.4% |
| 82 | Kidney Calculi | 8% |
| 83 | Ureteral Calculi | 8% |
| 84 | Chlamydia Infections | 7.6% |
| 85 | Gonorrhea | 7.6% |
| 86 | Hermaphroditism | 7.6% |
| 87 | Parathyroid Neoplasms | 7.6% |
| 88 | Peritoneal Neoplasms | 7.6% |
| 89 | Disorders of Sex Development | 7.6% |
| 90 | Thyroid Neoplasm | 7.6% |
| 91 | Thyroid carcinoma | 7.6% |
| 92 | Multiple Endocrine Neoplasia | 7.2% |
| 93 | Genital Diseases, Male | 6.9% |
| 94 | Syphilis | 6.9% |
| 95 | Pancreatic Neoplasm | 6.8% |
| 96 | Paraneoplastic Encephalomyelitis | 6.8% |
| 97 | Pyelocystitis | 6.7% |
| 98 | Mammary Neoplasms, Experimental | 6.7% |
| 99 | Cystitis | 6.6% |
| 100 | Hydronephrosis | 6.6% |
| 101 | Hyperoxaluria | 6.6% |
| 102 | Kidney Cortex Necrosis | 6.6% |
| 103 | Kidney Papillary Necrosis | 6.6% |
| 104 | Nephritis | 6.6% |
| 105 | Nephrosclerosis | 6.6% |
| 106 | Nephrosis | 6.6% |
| 107 | Perinephritis | 6.6% |
| 108 | Kidney Failure | 6.6% |
| 109 | Uremia | 6.6% |
| 110 | Ureteral obstruction | 6.6% |
| 111 | Ureterocele | 6.6% |
| 112 | Urethral Obstruction | 6.6% |
| 113 | Urethritis | 6.6% |
| 114 | Vesico-Ureteral Reflux | 6.6% |
| 115 | Urinary Retention | 6.6% |
| 116 | Oxalosis | 6.6% |
| 117 | Renal Insufficiency | 6.6% |
| 118 | Uterine Neoplasms | 6.5% |
| 119 | Vaginal Neoplasms | 6.5% |
| 120 | Vulvar Neoplasms | 6.5% |
| 121 | Uterine Cancer | 6.5% |
| 122 | Fallopian Tube Neoplasms | 6.5% |
| 123 | Tracheal Neoplasms | 6.3% |
| 124 | Lymphogranuloma Venereum | 6.3% |
| 125 | Hamartoma | 6.2% |
| 126 | Neoplasms, Hormone-Dependent | 6.2% |
| 127 | Neoplasms, Multiple Primary | 6.2% |
| 128 | Paraneoplastic Syndromes | 6.2% |
| 129 | Precancerous Conditions | 6.2% |
| 130 | Neoplasms, Second Primary | 6.2% |
| 131 | Pyelonephritis | 6.1% |
| 132 | Acanthoma | 6% |
| 133 | Retroperitoneal Neoplasms | 6% |
| 134 | Diabetes Insipidus | 5.7% |
| 135 | Hepatorenal Syndrome | 5.7% |
| 136 | Bacteriuria | 5.7% |
| 137 | Diabetic Nephropathy | 5.7% |
| 138 | Glycosuria | 5.7% |
| 139 | Hematuria | 5.7% |
| 140 | Renal hypertension | 5.7% |
| 141 | Oliguria | 5.7% |
| 142 | Polyuria | 5.7% |
| 143 | Proteinuria | 5.7% |
| 144 | Pyuria | 5.7% |
| 145 | Renal Artery Obstruction | 5.7% |
| 146 | Renal Artery Stenosis | 5.7% |
| 147 | Urinary Calculi | 5.7% |
| 148 | Cystocele | 5.6% |
| 149 | Nephrocalcinosis | 5.6% |
| 150 | Urinary Incontinence | 5.6% |
| 151 | Esophageal Neoplasms | 5.5% |
| 152 | Glycosuria, Renal | 5.3% |
| 153 | Cyst | 5.2% |
| 154 | Neoplastic Processes | 5.2% |
| 155 | Neoplastic Syndromes, Hereditary | 5.2% |
| 156 | Pregnancy Complications, Neoplastic | 5.2% |
| 157 | Neoplasms, Experimental | 5.1% |
| 158 | Carcinoma, Lobular | 5.1% |
| 159 | Mouth Neoplasms | 5% |
| 160 | Central Nervous System Neoplasms | 5% |
| 161 | Vascular Neoplasms | 5% |
| 162 | Thymus Neoplasms | 5% |
| 163 | Enuresis | 5% |
| 164 | Breast Neoplasms, Male | 4.9% |
| 165 | Triple Negative Breast Neoplasms | 4.9% |
| 166 | Gonadal Dysgenesis | 4.9% |
| 167 | Thyroid Nodule | 4.9% |
| 168 | Adrenogenital Syndrome | 4.9% |
| 169 | Ovotesticular Disorders of Sex Development | 4.9% |
| 170 | Glomerulonephritis | 4.9% |
| 171 | Nephritis, Interstitial | 4.9% |
| 172 | Lipoid nephrosis | 4.9% |
| 173 | Nephrotic Syndrome | 4.9% |
| 174 | Pyelitis | 4.9% |
| 175 | Pyonephrosis | 4.9% |
| 176 | Urethral Stenosis | 4.9% |
| 177 | Nephrogenic Diabetes Insipidus | 4.9% |
| 178 | Congenital Nephrogenic Diabetes Insipidus | 4.9% |
| 179 | Acute kidney injury | 4.9% |
| 180 | Urethral stricture | 4.9% |
| 181 | Endometrial Neoplasms | 4.9% |
| 182 | Hyperandrogenism | 4.9% |
| 183 | Neoplasms, Radiation-Induced | 4.4% |
| 184 | Multiple Endocrine Neoplasia Type 1 | 4.4% |
| 185 | Carcinoma, Pancreatic Ductal | 4.4% |
| 186 | AIDS-Associated Nephropathy | 4.4% |
| 187 | Adrenal Gland Neoplasms | 4.3% |
| 188 | Gastrointestinal Neoplasms | 4.3% |
| 189 | Liver neoplasms | 4.3% |
| 190 | Uveal Neoplasms | 4.3% |
| 191 | Meningioma | 4.3% |
| 192 | Sebaceous Gland Neoplasms | 4.3% |
| 193 | Spinal Neoplasms | 4.3% |
| 194 | Bone Marrow Neoplasms | 4.3% |
| 195 | Azotemia | 4.3% |
| 196 | Thymoma | 4.2% |
| 197 | Albuminuria | 4.2% |
| 198 | Hemoglobinuria | 4.2% |
| 199 | Hypertension, Renovascular | 4.2% |
| 200 | Urge Incontinence | 4.2% |
| 201 | Balkan Nephropathy | 4.1% |
| 202 | Focal glomerulosclerosis | 4.1% |
| 203 | Kidney Failure, Chronic | 4.1% |
| 204 | Liver Neoplasms, Experimental | 4.1% |
| 205 | Carcinoma 256, Walker | 4% |
| 206 | Tuberous Sclerosis | 3.9% |
| 207 | Carcinoma, Ehrlich Tumor | 3.9% |
| 208 | Dermoid Cyst | 3.9% |
| 209 | Carcinoma, Lewis Lung | 3.9% |
| 210 | Trophoblastic Neoplasms | 3.8% |
| 211 | Leukemia, Experimental | 3.8% |
| 212 | Leukoplakia, Oral | 3.7% |
| 213 | Paraneoplastic Cerebellar Degeneration | 3.7% |
| 214 | Polycystic Kidney Diseases | 3.7% |
| 215 | Nose Neoplasms | 3.7% |
| 216 | Diurnal Enuresis | 3.7% |
| 217 | Renal Aminoacidurias | 3.7% |
| 218 | Fanconi Syndrome | 3.7% |
| 219 | Pseudohypoaldosteronism | 3.7% |
| 220 | Liddle Syndrome | 3.7% |
| 221 | Hemolytic-Uremic Syndrome | 3.7% |
| 222 | Glomerulonephritis, Membranoproliferative | 3.6% |
| 223 | Acoustic Neuroma | 3.6% |
| 224 | Renal Osteodystrophy | 3.6% |
| 225 | Renal rickets | 3.6% |
| 226 | Melanoma, Experimental | 3.5% |
| 227 | Palatal Neoplasms | 3.4% |
| 228 | Turner Syndrome | 3.4% |
| 229 | insulinoma | 3.4% |
| 230 | Pituitary Adenoma | 3.4% |
| 231 | Pituitary Neoplasms | 3.4% |
| 232 | Vipoma | 3.4% |
| 233 | Leukemia, Radiation-Induced | 3.4% |
| 234 | Erythroplasia | 3.4% |
| 235 | Follicular cyst | 3.4% |
| 236 | leukemia | 3.4% |
| 237 | Mucocele | 3.4% |
| 238 | Neoplasms, Germ Cell and Embryonal | 3.4% |
| 239 | Neoplasms, Glandular and Epithelial | 3.4% |
| 240 | Pilonidal Cyst | 3.4% |
| 241 | Thyroglossal Cyst | 3.4% |
| 242 | Synovial Cyst | 3.4% |
| 243 | Germ Cell Cancer | 3.4% |
| 244 | Aberrant Crypt Foci | 3.4% |
| 245 | Gastrinoma | 3.3% |
| 246 | Glucagonoma | 3.3% |
| 247 | Sarcoma, Experimental | 3.3% |
| 248 | Neuroectodermal Tumors | 3.3% |
| 249 | ovarian neoplasm | 3.3% |
| 250 | Carcinoma, Endometrioid | 3.3% |
| 251 | Meningeal Neoplasms | 3.3% |
| 252 | Retinoblastoma | 3.3% |
| 253 | Hepatocellular Adenoma | 3.3% |
| 254 | Neoplasms, Neuroepithelial | 3.3% |
| 255 | Gliomatosis cerebri | 3.3% |
| 256 | Limbic Encephalitis | 3.3% |
| 257 | Renal tubular acidosis | 3.3% |
| 258 | Anti-Glomerular Basement Membrane Disease | 3.1% |
| 259 | Lupus Nephritis | 3.1% |
| 260 | Polycystic Kidney, Autosomal Dominant | 3% |
| 261 | Cystinuria | 3% |
| 262 | Atypical Hemolytic Uremic Syndrome | 3% |
| 263 | Lambert-Eaton Myasthenic Syndrome | 3% |
| 264 | Kallmann Syndrome | 3% |
| 265 | Prolactinoma | 2.9% |
| 266 | Growth Hormone-Secreting Pituitary Adenoma | 2.9% |
| 267 | Ear Neoplasms | 2.9% |
| 268 | Eyelid Neoplasms | 2.9% |
| 269 | Lung Neoplasms | 2.9% |
| 270 | Pleural Neoplasms | 2.9% |
| 271 | Brain Neoplasms | 2.8% |
| 272 | Salivary Gland Neoplasms | 2.8% |
| 273 | Spinal Cord Neoplasms | 2.8% |
| 274 | Tongue Neoplasms | 2.8% |
| 275 | Leukoplakia | 2.8% |
| 276 | Lymphocele | 2.8% |
| 277 | Pancreatic Cyst | 2.8% |
| 278 | Optic Nerve Glioma | 2.8% |
| 279 | Zellweger Syndrome | 2.8% |
| 280 | melanoma | 2.8% |
| 281 | Barrett Esophagus | 2.8% |
| 282 | Breast Cyst | 2.8% |
| 283 | Histiocytic Disorders, Malignant | 2.8% |
| 284 | Actinic keratosis | 2.8% |
| 285 | Mediastinal Cyst | 2.8% |
| 286 | Neoplasm Invasiveness | 2.8% |
| 287 | Neoplasm Metastasis | 2.8% |
| 288 | Neoplasm Recurrence, Local | 2.8% |
| 289 | Parovarian Cyst | 2.8% |
| 290 | Pericardial Cyst | 2.8% |
| 291 | Thymic Cyst | 2.8% |
| 292 | Carcinogenesis | 2.8% |
| 293 | Myxoid cyst | 2.8% |
| 294 | Metastasis | 2.8% |
| 295 | Carcinosarcoma | 2.7% |
| 296 | Hemangiosarcoma | 2.7% |
| 297 | Leukemia L1210 | 2.7% |
| 298 | Leukemia P388 | 2.7% |
| 299 | lymphangiosarcoma | 2.7% |
| 300 | Opsoclonus-Myoclonus Syndrome | 2.7% |
| 301 | Lymphomatoid Granulomatosis | 2.7% |
| 302 | Hyperphosphaturia | 2.7% |
| 303 | Choriocarcinoma | 2.7% |
| 304 | Klinefelter Syndrome | 2.7% |
| 305 | granulosa cell tumor | 2.6% |
| 306 | Carcinoma, Ovarian Epithelial | 2.6% |
| 307 | Medulloblastoma | 2.6% |
| 308 | Adenomatous Polyposis Coli | 2.6% |
| 309 | Pharyngeal Neoplasms | 2.5% |
| 310 | Central Nervous System Cysts | 2.5% |
| 311 | Bile Duct Neoplasms | 2.5% |
| 312 | gallbladder neoplasm | 2.5% |
| 313 | Intestinal Neoplasms | 2.5% |
| 314 | Stomach Neoplasms | 2.5% |
| 315 | Composite Lymphoma | 2.5% |
| 316 | Myelitis, Transverse | 2.5% |
| 317 | Sarcoma 180 | 2.5% |
| 318 | Meningeal Carcinomatosis | 2.5% |
| 319 | Polycythemia Vera | 2.4% |
| 320 | Basal Cell Nevus Syndrome | 2.4% |
| 321 | Lymphoma | 2.4% |
| 322 | Corpus Luteum Cyst | 2.4% |
| 323 | Ovarian Cysts | 2.4% |
| 324 | Leukemia, Plasma Cell | 2.3% |
| 325 | Adenoma, Acidophil | 2.3% |
| 326 | Ganglioneuroma | 2.3% |
| 327 | Glioma | 2.3% |
| 328 | Malignant Glioma | 2.3% |
| 329 | Laryngeal neoplasm | 2.3% |
| 330 | Basal cell carcinoma | 2.2% |
| 331 | Carcinoma, Papillary | 2.2% |
| 332 | Squamous cell carcinoma | 2.2% |
| 333 | Chondrosarcoma | 2.2% |
| 334 | Craniopharyngioma | 2.2% |
| 335 | Cystadenoma | 2.2% |
| 336 | leiomyosarcoma | 2.2% |
| 337 | liposarcoma | 2.2% |
| 338 | Mesothelioma | 2.2% |
| 339 | synovial sarcoma | 2.2% |
| 340 | Neuroectodermal Tumor, Melanotic | 2.2% |
| 341 | Angiomyolipoma | 2.2% |
| 342 | Clear Cell Sarcoma of Soft Tissue | 2.2% |
| 343 | Alveolar Soft Part Sarcoma | 2.2% |
| 344 | Neuroendocrine Tumors | 2.2% |
| 345 | Sarcoma, Myeloid | 2.2% |
| 346 | Carcinoma, Basal Cell | 2.2% |
| 347 | Adrenocortical carcinoma | 2.2% |
| 348 | Bronchial Neoplasms | 2.1% |
| 349 | Multiple Pulmonary Nodules | 2.1% |
| 350 | Choledochal Cyst | 2.1% |
| 351 | Supratentorial Neoplasms | 2.1% |
| 352 | Carcinoid Tumor | 2.1% |
| 353 | Neurilemmoma | 2.1% |
| 354 | Hutchinson's Melanotic Freckle | 2.1% |
| 355 | Melanoma, Amelanotic | 2.1% |
| 356 | Peutz-Jeghers Syndrome | 2.1% |
| 357 | Adenoma | 2% |
| 358 | Ameloblastoma | 2% |
| 359 | Angiokeratoma | 2% |
| 360 | Carcinoma | 2% |
| 361 | Chordoma | 2% |
| 362 | Hemangioma | 2% |
| 363 | hemangiopericytoma | 2% |
| 364 | Lymphangioma | 2% |
| 365 | Mesenchymoma | 2% |
| 366 | Nevus | 2% |
| 367 | Teratoma | 2% |
| 368 | Hepatoblastoma | 2% |
| 369 | Mixed Tumor, Mullerian | 2% |
| 370 | Germinoma | 2% |
| 371 | Teratocarcinoma | 2% |
| 372 | Angiofibroma | 2% |
| 373 | Sarcoma | 2% |
| 374 | Epithelioma | 2% |
| 375 | Cystadenocarcinoma | 1.9% |
| 376 | Fibrosarcoma | 1.9% |
| 377 | Osteosarcoma | 1.9% |
| 378 | Mucoepidermoid Carcinoma | 1.9% |
| 379 | Hypopharyngeal Neoplasms | 1.9% |
| 380 | Pleural Effusion, Malignant | 1.9% |
| 381 | Hypopharyngeal Cancer | 1.9% |
| 382 | Astrocytoma | 1.9% |
| 383 | Ependymoma | 1.9% |
| 384 | oligodendroglioma | 1.9% |
| 385 | Ganglioglioma | 1.9% |
| 386 | gliosarcoma | 1.9% |
| 387 | Anaplastic astrocytoma | 1.9% |
| 388 | Anaplastic Oligodendroglioma | 1.9% |
| 389 | Parotid Neoplasms | 1.8% |
| 390 | Endometrial Stromal Sarcoma | 1.8% |
| 391 | Nelson Syndrome | 1.8% |
| 392 | Adenofibroma | 1.8% |
| 393 | Fibroadenoma | 1.8% |
| 394 | Malignant Fibrous Histiocytoma | 1.8% |
| 395 | Brain Stem Neoplasms | 1.7% |
| 396 | Malignant Carcinoid Syndrome | 1.7% |
| 397 | Nasopharyngeal carcinoma | 1.7% |
| 398 | Pancreatic Pseudocyst | 1.7% |
| 399 | Plasmacytoma | 1.7% |
| 400 | Malignant histiocytosis | 1.6% |
| 401 | Lymphatic Metastasis | 1.6% |
| 402 | Neoplasms, Unknown Primary | 1.6% |
| 403 | Leukemic Infiltration | 1.6% |
| 404 | Histiocytic sarcoma | 1.6% |
| 405 | Neoplasm Micrometastasis | 1.6% |
| 406 | Lymphangioleiomyomatosis | 1.6% |
| 407 | Bowen's Disease | 1.6% |
| 408 | Paraganglioma | 1.6% |
| 409 | Rhabdomyosarcoma | 1.6% |
| 410 | Giant Cell Tumor of Bone | 1.6% |
| 411 | Hydatidiform Mole | 1.6% |
| 412 | Cecal Neoplasms | 1.6% |
| 413 | Duodenal Neoplasms | 1.6% |
| 414 | Glioblastoma | 1.6% |
| 415 | Neuroblastoma | 1.6% |
| 416 | Glioblastoma Multiforme | 1.6% |
| 417 | Choroid Plexus Papilloma | 1.6% |
| 418 | Tonsillar Neoplasms | 1.5% |
| 419 | Neurofibrosarcoma | 1.5% |
| 420 | Cerebellar Neoplasms | 1.5% |
| 421 | Familial Hypophosphatemic Rickets | 1.5% |
| 422 | Ganglioneuroblastoma | 1.5% |
| 423 | Dermatofibrosarcoma | 1.5% |
| 424 | Dermatofibrosarcoma Protuberans | 1.5% |
| 425 | Nasopharyngeal Neoplasms | 1.5% |
| 426 | Colorectal Neoplasms | 1.5% |
| 427 | Hodgkin Disease | 1.4% |
| 428 | Lymphoma, Non-Hodgkin | 1.4% |
| 429 | Polycystic Ovary Syndrome | 1.4% |
| 430 | Xeroderma Pigmentosum | 1.4% |
| 431 | Carcinoid Heart Disease | 1.4% |
| 432 | Pheochromocytoma | 1.4% |
| 433 | Alveolar rhabdomyosarcoma | 1.4% |
| 434 | Paranasal Sinus Neoplasms | 1.4% |
| 435 | Appendiceal Neoplasms | 1.3% |
| 436 | Colonic Neoplasms | 1.3% |
| 437 | Rectal Neoplasms | 1.3% |
| 438 | Adenocarcinoma | 1.3% |
| 439 | Carcinoma in Situ | 1.3% |
| 440 | Carcinoma, Transitional Cell | 1.3% |
| 441 | Phyllodes Tumor | 1.3% |
| 442 | Dysgerminoma | 1.3% |
| 443 | Hemangioendothelioma | 1.3% |
| 444 | Lipoma | 1.3% |
| 445 | Myoma | 1.3% |
| 446 | Myxoma | 1.3% |
| 447 | Neuroma | 1.3% |
| 448 | Papilloma | 1.3% |
| 449 | Pseudomyxoma Peritonei | 1.3% |
| 450 | Seminoma | 1.3% |
| 451 | Papillomatosis | 1.3% |
| 452 | Angiolipoma | 1.3% |
| 453 | Myelolipoma | 1.3% |
| 454 | Neoplasms, Bone Tissue | 1.3% |
| 455 | Neoplasms, Fibrous Tissue | 1.3% |
| 456 | Smooth Muscle Tumor | 1.3% |
| 457 | Adenomatosis, Pulmonary | 1.3% |
| 458 | Adenomatous Polyps | 1.3% |
| 459 | Carcinoma, Large Cell | 1.3% |
| 460 | Carcinoma, Small Cell | 1.3% |
| 461 | Desmoplastic Small Round Cell Tumor | 1.3% |
| 462 | Chondroma | 1.3% |
| 463 | Enchondroma | 1.3% |
| 464 | Primary amyloidosis | 1.2% |
| 465 | Maxillary Sinus Neoplasms | 1.1% |
| 466 | Leukemia, Myelomonocytic, Chronic | 1.1% |
| 467 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 1.1% |
| 468 | Anus Neoplasms | 1.1% |
| 469 | Sigmoid Neoplasms | 1.1% |
| 470 | Waldenstrom Macroglobulinemia | 1% |
| 471 | Multiple Myeloma | 1% |
| 472 | Adenoid Cystic Carcinoma | 1% |
| 473 | fibroma | 1% |
| 474 | Fibromatosis | 1% |
| 475 | Osteoblastoma | 1% |
| 476 | Osteoma | 1% |
| 477 | Rhabdomyoma | 1% |
| 478 | Chondromatosis | 1% |
| 479 | Adenocarcinoma, Clear Cell | 1% |
| 480 | Cholangiocarcinoma | 1% |
| 481 | Cervical Intraepithelial Neoplasia | 1% |
| 482 | Hemangioblastoma | 1% |
| 483 | Lymphoma, Extranodal NK-T-Cell | 1% |
| 484 | Mastocytosis | 1% |
| 485 | Sturge-Weber Syndrome | 1% |
| 486 | Cell Transformation, Viral | 0.9% |
| 487 | Gastrointestinal Stromal Tumors | 0.9% |
| 488 | Hemangioma, Cavernous | 0.9% |
| 489 | Leukemia, T-Cell | 0.9% |
| 490 | Leukemia, B-Cell | 0.9% |
| 491 | neurofibroma | 0.9% |
| 492 | Lymphoma, Follicular | 0.9% |
| 493 | T-Cell Lymphoma | 0.9% |
| 494 | Mantle cell lymphoma | 0.9% |
| 495 | Zollinger-Ellison syndrome | 0.9% |
| 496 | Mastocytoma | 0.8% |
| 497 | Fibromatosis, Aggressive | 0.8% |
| 498 | Fibromatosis, Abdominal | 0.8% |
| 499 | Klatskin Tumor | 0.8% |
| 500 | Mastocytosis, Systemic | 0.8% |
| 501 | Leukemia, Myeloid, Chronic-Phase | 0.8% |
| 502 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 0.7% |
| 503 | Leukemia, Large Granular Lymphocytic | 0.7% |
| 504 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.7% |
| 505 | Lymphoma, T-Cell, Cutaneous | 0.7% |
| 506 | Lymphoma, AIDS-Related | 0.7% |
| 507 | Enteropathy-Associated T-Cell Lymphoma | 0.7% |
| 508 | Primary Effusion Lymphoma | 0.7% |
| 509 | Dupuytren Contracture | 0.6% |
| 510 | Urticaria Pigmentosa | 0.6% |
| 511 | Mycosis Fungoides | 0.6% |
| 512 | Lymphomatoid Papulosis | 0.6% |
| 513 | Plasmablastic lymphoma | 0.6% |
| 514 | Burkitt Lymphoma | 0.5% |
| 515 | Sezary Syndrome | 0.5% |
| 516 | Radicular Cyst | 0.5% |
